BioPharmSignal logoBioPharmSignal

Biotech News

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

Outset Medical (OM)Outset MedicalCommercial

SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced the appointment of Derick Elliott as Executive Vice

Related news

SSKNStrata Skin Sciences2026-07-28 13:15 EST

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer

PAVMPAVmed2026-08-05 12:46 EST

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

IARTIntegra LifeSciences2026-06-23 12:00 EST

Integra LifeSciences Announces Key Executive Appointments

ICCMIceCure Medical2026-07-14 12:32 EST

IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation

CVRXCVRx2026-08-24 12:30 EST

CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

CVRXCVRx2026-08-11 11:00 EST

CVRx Announces Sales Leadership Transition

NEPHNephros2026-07-06 11:00 EST

Nephros Announces Inclusion in the Russell Microcap® Index

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

PAVMPAVmed2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

View all latest news

Outset Medical

Dialysis Technology Outset Medical develops technology intended to simplify dialysis delivery across hospitals, clinics and home-care settings. Tablo Hemodialysis System Tablo is an integrated hemodialysis system that combines water purification, on-demand dialysate production and treatment delivery in a single device. Its design seeks...

Recent company news

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

OMOutset Medical2026-07-02 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-21 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-11 20:05 EST

Outset Medical to Present at RBC Global Healthcare Conference

Stock data

Close
4.21 USD
Market cap
93.98M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States